15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
Olema Pharmaceuticals Inc. (OLMA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 1,873,704 | $21,210,329 | 1.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.09 | 50,000 | Director | 1,800,000 | 2023-12-05 | Filing | |
| $14.95 | 50,000 | Director | 1,750,000 | 2023-12-05 | Filing | |
| $14.73 | 31,870 | Director | 1,700,000 | 2023-12-05 | Filing | |
| $9.84 | 508,130 | Director | 1,668,130 | 2023-09-12 | Filing | |
| $11.60 | 100,000 | Large Shareholder | 6,590,981 | 2023-12-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.97 | 20,000 | 826,283 | 2024-03-28 | Filing | ||
| $13.00 | 100 | 846,283 | 2024-02-29 | Filing | ||
| $12.41 | 24,900 | 846,383 | 2024-02-29 | Filing | ||
| $15.56 | 5,000 | 871,283 | 2024-02-01 | Filing | ||
| $12.23 | 25,000 | 876,283 | 2024-01-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,903,600 | $110,887,508 | 5.19% | |
| 2. | 3,263,907 | $45,792,615 | 0% | |
| 3. | 2,705,895 | $37,963,707 | 0% | |
| 4. | 1,715,420 | $24,068,813 | 0% | |
| 5. | 824,833 | $11,574,367 | 0% |
News See All
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
5 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the five best performing biotechnology stocks in 2023.
8 Stocks in Eashwar Krishnan's Tybourne Capital Management Portfolio
In this article, we will take a look at some of the stocks in Eashwar Krishnan’s Tybourne Capital Management portfolio.
5 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Hedge Fund and Insider Trading News: York Capital Management, Point72 Asset Management, Elliott Advisors, Cresco Labs Inc (CRLBF), Estee Lauder Companies Inc (EL), and More
Blackstart Capital, which listed $319 million under management on a recent disclosure form, has terminated its registration with the Securities and Exchange Commission.
Billionaire Hedge Funds
